Fabry disease in Australia part 3: a patient’s story

Hereditary Diseases Pod

English - January 17, 2020 00:33 - 19 minutes - 43.9 MB
Medicine Health & Fitness Science Life Sciences australia disease hereditary acroparesthesias andrewkornberg anhidrosis associate carolynellaway clinical cornealverticillate Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Fabry disease in Australia part 1: what is Fabry disease?

Next Episode: Fabry disease in Australia part 2: the local experience

In the concluding episode, Associate Professor Carolyn Ellaway evaluates the management of Fabry disease in Australia from her patient’s perspective, reviewing their journey from mystery illness to treatable disease. Intended for healthcare professional audiences.

For more information about diagnostic testing, please visit sanofigenzymeonline.com.au/diagnostics

See episode website for full notes, including references & legal information.

The views and opinions expressed in the presentation are solely those of Associate Professor Carolyn Ellaway and Associate Professor Andrew Kornberg and should not be attributed to any organisation with which the presenter is employed or affiliated and are not necessarily the views of Sanofi Genzyme.

sanofi‐aventis australia pty ltd trading as Sanofi Genzyme. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2102516. Date of preparation December 2021. 2200137.